Current Offer for Select Genes

Pairnomix launched at the start of 2016 with the goal of enabling the practice of precision medicine. We are committed to improving the lives of people with rare disease through our personalized genetic research services. We work with top genetic researchers, provide a very high level of support for our patients, and generate comprehensive reports that are reviewed by our world-class advisory board.

At the outset, our services will be costly and Pairnomix will work closely with each individual to price out a research program that includes characterization of the mutation and drug screening. Over time, as science and technology advance, we will move toward more economical models and seek out paths for financial support including the potential for insurance coverage.

Currently, in addition to evaluating all patient inquiries, Pairnomix offers immediately available research services for the following genes: